Allan Friedman, MD - Publications

Affiliations: 
1996-2014 Neurosurgery Duke University, Durham, NC 

123 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Desjardins A, Herndon JE, McSherry F, Ravelo A, Lipp ES, Healy P, Peters KB, Sampson JH, Randazzo D, Sommer N, Friedman AH, Friedman HS. Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice. Health Science Reports. 2: e114. PMID 31049419 DOI: 10.1002/hsr2.114  0.44
2019 Hansen LJ, Sun R, Yang R, Singh SX, Chen LH, Pirozzi CJ, Moure CJ, Hemphill C, Carpenter AB, Healy P, Ruger RC, Chen CJ, Greer PK, Zhao F, Spasojevic I, ... ... Friedman AH, et al. MTAP loss promotes stemness in glioblastoma and confers unique susceptibility to purine starvation. Cancer Research. PMID 31040154 DOI: 10.1158/0008-5472.CAN-18-1010  0.44
2019 Lipp ES, Healy P, Austin A, Clark A, Dalton T, Perkinson K, Herndon JE, Friedman HS, Friedman AH, Bigner DD, McLendon RE. MGMT: Immunohistochemical Detection in High-Grade Astrocytomas. Journal of Neuropathology and Experimental Neurology. 78: 57-64. PMID 30500933 DOI: 10.1093/jnen/nly110  0.44
2018 Desjardins A, Gromeier M, Herndon JE, Beaubier N, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Nair S, Peters KB, Randazzo D, Sampson JH, Vlahovic G, Harrison WT, et al. Recurrent Glioblastoma Treated with Recombinant Poliovirus. The New England Journal of Medicine. PMID 29943666 DOI: 10.1056/NEJMoa1716435  0.44
2018 Diplas BH, He X, Brosnan-Cashman JA, Liu H, Chen LH, Wang Z, Moure CJ, Killela PJ, Loriaux DB, Lipp ES, Greer PK, Yang R, Rizzo AJ, Rodriguez FJ, Friedman AH, et al. The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma. Nature Communications. 9: 2087. PMID 29802247 DOI: 10.1038/s41467-018-04448-6  0.44
2017 Reap E, Suryadevara CM, Batich KA, Sanchez-Perez L, Archer GE, Schmittling RJ, Norberg PK, Herndon JE, Healy P, Congdon KL, Gedeon PC, Campbell OC, Swartz AM, Riccione KA, Yi JS, ... ... Friedman AH, et al. Dendritic cells enhance polyfunctionality of adoptively transferred T cells which target cytomegalovirus in glioblastoma. Cancer Research. PMID 29093005 DOI: 10.1158/0008-5472.CAN-17-0469  0.44
2017 Sampson JH, Haglund MM, Friedman AH, Ewend MG. Obituary. Robert H. Wilkins, MD, 1934-2017. Journal of Neurosurgery. 1-2. PMID 29027856 DOI: 10.3171/2017.6.JNS171416  0.44
2017 Ewend MG, Friedman AH, Sampson JH. In Memoriam: Robert H. Wilkins, MD, 1934 to 2017. Neurosurgery. 81: 6-8. PMID 28873999 DOI: 10.1093/neuros/nyx283  0.44
2017 Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, Norberg P, Xie W, Herndon JE, Healy P, McLendon RE, Friedman AH, Friedman HS, Bigner D, Vlahovic G, et al. Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 1898-1909. PMID 28411277 DOI: 10.1158/1078-0432.CCR-16-2057  0.44
2016 Watanabe K, Tubbs RS, Satoh S, Zomorodi AR, Liedtke W, Labidi M, Friedman AH, Fukushima T. Isolated Deep Ear Canal Pain: Possible Role of the Auricular branch of the Vagus Nerve. Case Illustrations with Cadaveric Correlation. World Neurosurgery. PMID 27593717 DOI: 10.1016/j.wneu.2016.08.102  0.44
2016 Berger M, Nadler JW, Friedman A, McDonagh DL, Bennett ER, Cooter M, Qi W, Laskowitz DT, Ponnusamy V, Newman MF, Shaw LM, Warner DS, Mathew JP, James ML. The Effect of Propofol Versus Isoflurane Anesthesia on Human Cerebrospinal Fluid Markers of Alzheimer's Disease: Results of a Randomized Trial. Journal of Alzheimer's Disease : Jad. PMID 27079717 DOI: 10.3233/JAD-151190  0.44
2016 Nonaka Y, Fukushima T, Watanabe K, Friedman AH, Cunningham CD, Zomorodi AR. Surgical management of vestibular schwannomas after failed radiation treatment. Neurosurgical Review. PMID 26782633 DOI: 10.1007/s10143-015-0690-7  0.44
2016 Hu J, Sun T, Wang H, Chen Z, Wang S, Yuan L, Liu T, Li HR, Wang P, Feng Y, Wang Q, McLendon RE, Friedman AH, Keir ST, Bigner DD, et al. MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B. Cancer Cell. 29: 49-60. PMID 26766590 DOI: 10.1016/j.ccell.2015.12.005  0.44
2015 Nabors LB, Portnow J, Ammirati M, Baehring J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Holdhoff M, Junck L, Kaley T, et al. Central Nervous System Cancers, Version 1.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 1191-202. PMID 26483059  0.44
2015 Babu R, Komisarow JM, Agarwal VJ, Rahimpour S, Iyer A, Britt D, Karikari IO, Grossi PM, Thomas S, Friedman AH, Adamson C. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. Journal of Neurosurgery. 1-10. PMID 26452121 DOI: 10.3171/2015.4.JNS142200  0.44
2015 Mitchell DA, Batich KA, Gunn MD, Huang MN, Sanchez-Perez L, Nair SK, Congdon KL, Reap EA, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE, Coan A, McLendon RE, et al. Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients. Nature. 519: 366-9. PMID 25762141 DOI: 10.1038/nature14320  0.44
2015 Karikari IO, Nimjee SM, Hodges TR, Cutrell E, Hughes BD, Powers CJ, Mehta AI, Hardin C, Bagley CA, Isaacs RE, Haglund MM, Friedman AH. Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: a single-center experience with 102 patients. Neurosurgery. 76: S4-13; discussion S1. PMID 25692367 DOI: 10.1227/01.neu.0000462073.71915.12  0.44
2015 Mitchell DA, Sayour EJ, Reap E, Schmittling R, DeLeon G, Norberg P, Desjardins A, Friedman AH, Friedman HS, Archer G, Sampson JH. Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide. Cancer Immunology Research. 3: 320-5. PMID 25387895 DOI: 10.1158/2326-6066.CIR-14-0100  0.44
2014 Nabors LB, Portnow J, Ammirati M, Brem H, Brown P, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hattangadi-Gluth J, Hesser D, Holdhoff M, Junck L, et al. Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network : Jnccn. 12: 1517-23. PMID 25361798  0.44
2014 Wang H, Sun T, Hu J, Zhang R, Rao Y, Wang S, Chen R, McLendon RE, Friedman AH, Keir ST, Bigner DD, Li QJ, Wang H, Wang XF. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. The Journal of Clinical Investigation. 124: 4489-502. PMID 25202981 DOI: 10.1172/JCI75284  0.44
2014 Kanaly CW, Mehta AI, Ding D, Hoang JK, Kranz PG, Herndon JE, Coan A, Crocker I, Waller AF, Friedman AH, Reardon DA, Sampson JH. A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma. Journal of Neurosurgery. 121: 536-42. PMID 25036205 DOI: 10.3171/2014.4.JNS121952  0.44
2014 Babu R, Thomas S, Hazzard MA, Lokhnygina YV, Friedman AH, Gottfried ON, Isaacs RE, Boakye M, Patil CG, Bagley CA, Haglund MM, Lad SP. Morbidity, mortality, and health care costs for patients undergoing spine surgery following the ACGME resident duty-hour reform: Clinical article. Journal of Neurosurgery. Spine. 21: 502-15. PMID 24995600 DOI: 10.3171/2014.5.SPINE13283  0.44
2014 Brown MC, Dobrikova EY, Dobrikov MI, Walton RW, Gemberling SL, Nair SK, Desjardins A, Sampson JH, Friedman HS, Friedman AH, Tyler DS, Bigner DD, Gromeier M. Oncolytic polio virotherapy of cancer. Cancer. 120: 3277-86. PMID 24939611 DOI: 10.1002/cncr.28862  0.44
2014 Babu R, Thomas S, Hazzard MA, Friedman AH, Sampson JH, Adamson C, Zomorodi AR, Haglund MM, Patil CG, Boakye M, Lad SP. Worse outcomes for patients undergoing brain tumor and cerebrovascular procedures following the ACGME resident duty-hour restrictions. Journal of Neurosurgery. 121: 262-76. PMID 24926647 DOI: 10.3171/2014.5.JNS1314  0.44
2014 Zhang L, Chen LH, Wan H, Yang R, Wang Z, Feng J, Yang S, Jones S, Wang S, Zhou W, Zhu H, Killela PJ, Zhang J, Wu Z, Li G, ... ... Friedman AH, et al. Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas. Nature Genetics. 46: 726-30. PMID 24880341 DOI: 10.1038/ng.2995  0.44
2014 Babu R, Kranz PG, Agarwal V, McLendon RE, Thomas S, Friedman AH, Bigner DD, Adamson C. Malignant brainstem gliomas in adults: clinicopathological characteristics and prognostic factors. Journal of Neuro-Oncology. 119: 177-85. PMID 24838419 DOI: 10.1007/s11060-014-1471-9  0.44
2014 Wanibuchi M, Fukushima T, Friedman AH, Watanabe K, Akiyama Y, Mikami T, Iihoshi S, Murakami T, Sugino T, Mikuni N. Hearing preservation surgery for vestibular schwannomas via the retrosigmoid transmeatal approach: surgical tips. Neurosurgical Review. 37: 431-44; discussion 4. PMID 24752423 DOI: 10.1007/s10143-014-0543-9  0.44
2014 Killela PJ, Pirozzi CJ, Healy P, Reitman ZJ, Lipp E, Rasheed BA, Yang R, Diplas BH, Wang Z, Greer PK, Zhu H, Wang CY, Carpenter AB, Friedman H, Friedman AH, et al. Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. Oncotarget. 5: 1515-25. PMID 24722048  0.44
2014 Choi BD, DeLong MR, DeLong DM, Friedman AH, Sampson JH. Impact of PhD training on scholarship in a neurosurgical career. Journal of Neurosurgery. 120: 730-5. PMID 24359004 DOI: 10.3171/2013.11.JNS122370  0.44
2014 Killela PJ, Pirozzi CJ, Reitman ZJ, Jones S, Rasheed BA, Lipp E, Friedman H, Friedman AH, He Y, McLendon RE, Bigner DD, Yan H. The genetic landscape of anaplastic astrocytoma. Oncotarget. 5: 1452-7. PMID 24140581  0.44
2014 Nonaka Y, Fukushima T, Friedman AH, Kolb LE, Bulsara KR. Surgical management of nonvascular lesions around the oculomotor nerve. World Neurosurgery. 81: 798-809. PMID 23182737 DOI: 10.1016/j.wneu.2012.11.067  0.44
2013 Sameshima T, Morita A, Tanikawa R, Fukushima T, Friedman AH, Zenga F, Ducati A, Mastronardi L. Evaluation of variation in the course of the facial nerve, nerve adhesion to tumors, and postoperative facial palsy in acoustic neuroma. Journal of Neurological Surgery. Part B, Skull Base. 74: 39-43. PMID 24436886 DOI: 10.1055/s-0032-1329625  0.44
2013 Agarwal V, Babu R, Grier J, Adogwa O, Back A, Friedman AH, Fukushima T, Adamson C. Cerebellopontine angle meningiomas: postoperative outcomes in a modern cohort. Neurosurgical Focus. 35: E10. PMID 24289118 DOI: 10.3171/2013.10.FOCUS13367  0.44
2013 Mehta AI, Adogwa O, Karikari IO, Thompson P, Verla T, Null UT, Friedman AH, Cheng JS, Bagley CA, Isaacs RE. Anatomical location dictating major surgical complications for intradural extramedullary spinal tumors: a 10-year single-institutional experience. Journal of Neurosurgery. Spine. 19: 701-7. PMID 24116680 DOI: 10.3171/2013.9.SPINE12913  0.44
2013 Nabors LB, Ammirati M, Bierman PJ, Brem H, Butowski N, Chamberlain MC, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Holdhoff M, Junck L, Lawson R, Loeffler JS, et al. Central nervous system cancers. Journal of the National Comprehensive Cancer Network : Jnccn. 11: 1114-51. PMID 24029126  0.44
2013 Babu R, Kranz PG, Karikari IO, Friedman AH, Adamson C. Clinical characteristics and treatment of malignant brainstem gliomas in elderly patients. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 20: 1382-6. PMID 23850399 DOI: 10.1016/j.jocn.2012.12.011  0.44
2013 Nonaka Y, Fukushima T, Watanabe K, Friedman AH, McElveen JT, Cunningham CD, Zomorodi AR. Less invasive transjugular approach with Fallopian bridge technique for facial nerve protection and hearing preservation in surgery of glomus jugulare tumors. Neurosurgical Review. 36: 579-86; discussion 5. PMID 23739840 DOI: 10.1007/s10143-013-0482-x  0.44
2013 Ouyang MW, McDonagh DL, Phillips-Bute B, James ML, Friedman AH, Gan TJ. Comparison of postoperative nausea between benign and malignant brain tumor patients undergoing awake craniotomy: a retrospective analysis. Current Medical Research and Opinion. 29: 1039-44. PMID 23731201 DOI: 10.1185/03007995.2013.811070  0.44
2013 Ouyang MW, McDonagh DL, Phillips-Bute B, James ML, Friedman AH, Gan TJ. Does midline shift predict postoperative nausea in brain tumor patients undergoing awake craniotomy? A retrospective analysis. Current Medical Research and Opinion. 29: 1033-8. PMID 23731200 DOI: 10.1185/03007995.2013.811071  0.44
2013 Babu R, Sharma R, Karikari IO, Owens TR, Friedman AH, Adamson C. Outcome and prognostic factors in adult cerebellar glioblastoma. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 20: 1117-21. PMID 23706183 DOI: 10.1016/j.jocn.2012.12.006  0.44
2013 Babu R, Bagley JH, Park JG, Friedman AH, Adamson C. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology. Journal of Neurosurgery. 119: 434-41. PMID 23662821 DOI: 10.3171/2013.4.JNS122329  0.44
2013 Babu R, Hatef J, McLendon RE, Cummings TJ, Sampson JH, Friedman AH, Adamson C. Clinicopathological characteristics and treatment of rhabdoid glioblastoma. Journal of Neurosurgery. 119: 412-9. PMID 23641829 DOI: 10.3171/2013.3.JNS121773  0.44
2013 Lad SP, Babu R, Rhee MS, Franklin RL, Ugiliweneza B, Hodes J, Nimjee SM, Zomorodi AR, Smith TP, Friedman AH, Patil CG, Boakye M. Long-term economic impact of coiling vs clipping for unruptured intracranial aneurysms. Neurosurgery. 72: 1000-11; discussion . PMID 23612602 DOI: 10.1227/01.neu.0000429284.91142.56  0.44
2013 Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, Friedman AH, Friedman H, Gallia GL, Giovanella BC, Grollman AP, He TC, He Y, Hruban RH, Jallo GI, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proceedings of the National Academy of Sciences of the United States of America. 110: 6021-6. PMID 23530248 DOI: 10.1073/pnas.1303607110  0.44
2013 Babu R, Sharma R, Bagley JH, Hatef J, Friedman AH, Adamson C. Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. Journal of Neurosurgery. 119: 121-30. PMID 23432451 DOI: 10.3171/2013.1.JNS121370  0.44
2013 Mehta AI, Babu R, Sharma R, Karikari IO, Grunch BH, Owens TR, Agarwal VJ, Sampson JH, Lad SP, Friedman AH, Kuchibhatla M, Bagley CA, Gottfried ON. Thickness of subcutaneous fat as a risk factor for infection in cervical spine fusion surgery. The Journal of Bone and Joint Surgery. American Volume. 95: 323-8. PMID 23426766 DOI: 10.2106/JBJS.L.00225  0.44
2013 Zhang J, Babu R, McLendon RE, Friedman AH, Adamson C. A comprehensive analysis of 41 patients with rosette-forming glioneuronal tumors of the fourth ventricle. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 20: 335-41. PMID 23375398 DOI: 10.1016/j.jocn.2012.09.003  0.44
2013 Bagley JH, Babu R, Friedman AH, Adamson C. Improved survival in the largest national cohort of adults with cerebellar versus supratentorial low-grade astrocytomas. Neurosurgical Focus. 34: E7. PMID 23373452 DOI: 10.3171/2012.12.FOCUS12343  0.44
2013 Nonaka Y, Fukushima T, Watanabe K, Friedman AH, Sampson JH, Mcelveen JT, Cunningham CD, Zomorodi AR. Contemporary surgical management of vestibular schwannomas: analysis of complications and lessons learned over the past decade. Neurosurgery. 72: ons103-15; discussio. PMID 23037828 DOI: 10.1227/NEU.0b013e3182752b05  0.44
2013 Kusumi M, Fukushima T, Mehta AI, Cunningham CD, Friedman AH, Fujii K. Middle fossa approach for total resection of petrous apex cholesterol granulomas: use of vascularized galeofascial flap preventing recurrence. Neurosurgery. 72: 77-86; discussion 86. PMID 22986599 DOI: 10.1227/NEU.0b013e3182724354  0.44
2012 Jiao Y, Killela PJ, Reitman ZJ, Rasheed AB, Heaphy CM, de Wilde RF, Rodriguez FJ, Rosemberg S, Oba-Shinjo SM, Nagahashi Marie SK, Bettegowda C, Agrawal N, Lipp E, Pirozzi C, Lopez G, ... ... Friedman AH, et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget. 3: 709-22. PMID 22869205  0.44
2012 Ohue S, Fukushima T, Kumon Y, Ohnishi T, Friedman AH. Preauricular transzygomatic anterior infratemporal fossa approach for tumors in or around infratemporal fossa lesions. Neurosurgical Review. 35: 583-92; discussion 5. PMID 22527629 DOI: 10.1007/s10143-012-0389-y  0.44
2012 Babu R, Bagley JH, Di C, Friedman AH, Adamson C. Thrombin and hemin as central factors in the mechanisms of intracerebral hemorrhage-induced secondary brain injury and as potential targets for intervention. Neurosurgical Focus. 32: E8. PMID 22463118 DOI: 10.3171/2012.1.FOCUS11366  0.44
2012 Choi BD, Mehta AI, Batich KA, Friedman AH, Sampson JH. The use of motor mapping to aid resection of eloquent gliomas. Neurosurgery Clinics of North America. 23: 215-25, vii. PMID 22440865 DOI: 10.1016/j.nec.2012.01.013  0.44
2012 Sampson JH, Schmittling RJ, Archer GE, Congdon KL, Nair SK, Reap EA, Desjardins A, Friedman AH, Friedman HS, Herndon JE, Coan A, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, et al. A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma. Plos One. 7: e31046. PMID 22383993 DOI: 10.1371/journal.pone.0031046  0.44
2012 Mehta AI, Choi BD, Ajay D, Raghavan R, Brady M, Friedman AH, Pastan I, Bigner DD, Sampson JH. Convection enhanced delivery of macromolecules for brain tumors. Current Drug Discovery Technologies. 9: 305-10. PMID 22339074  0.44
2012 Kusumi M, Fukushima T, Mehta AI, Aliabadi H, Nonaka Y, Friedman AH, Fujii K. Tentorial detachment technique in the combined petrosal approach for petroclival meningiomas. Journal of Neurosurgery. 116: 566-73. PMID 22196100 DOI: 10.3171/2011.11.JNS11985  0.44
2012 Mehta AI, Babu R, Karikari IO, Grunch B, Agarwal VJ, Owens TR, Friedman AH, Bagley CA, Gottfried ON. 2012 Young Investigator Award winner: The distribution of body mass as a significant risk factor for lumbar spinal fusion postoperative infections. Spine. 37: 1652-6. PMID 22146285 DOI: 10.1097/BRS.0b013e318241b186  0.44
2012 Reardon DA, Desjardins A, Peters KB, Gururangan S, Sampson JH, McLendon RE, Herndon JE, Bulusu A, Threatt S, Friedman AH, Vredenburgh JJ, Friedman HS. Phase II study of carboplatin, irinotecan, and bevacizumab for bevacizumab naïve, recurrent glioblastoma. Journal of Neuro-Oncology. 107: 155-64. PMID 21986722 DOI: 10.1007/s11060-011-0722-2  0.44
2012 Wanibuchi M, Fukushima T, Zomordi AR, Nonaka Y, Friedman AH. Trigeminal schwannomas: skull base approaches and operative results in 105 patients. Neurosurgery. 70: 132-43; discussion 1. PMID 21796003 DOI: 10.1227/NEU.0b013e31822efb21  0.44
2012 Vredenburgh JJ, Desjardins A, Kirkpatrick JP, Reardon DA, Peters KB, Herndon JE, Marcello J, Bailey L, Threatt S, Sampson J, Friedman A, Friedman HS. Addition of bevacizumab to standard radiation therapy and daily temozolomide is associated with minimal toxicity in newly diagnosed glioblastoma multiforme. International Journal of Radiation Oncology, Biology, Physics. 82: 58-66. PMID 21036490 DOI: 10.1016/j.ijrobp.2010.08.058  0.44
2011 Mehta AI, Choi BD, Raghavan R, Brady M, Friedman AH, Bigner DD, Pastan I, Sampson JH. Imaging of convection enhanced delivery of toxins in humans. Toxins. 3: 201-6. PMID 22069706 DOI: 10.3390/toxins3030201  0.44
2011 Mehta AI, Kanaly CW, Friedman AH, Bigner DD, Sampson JH. Monitoring radiographic brain tumor progression. Toxins. 3: 191-200. PMID 22069705 DOI: 10.3390/toxins3030191  0.44
2011 Mitchell DA, Cui X, Schmittling RJ, Sanchez-Perez L, Snyder DJ, Congdon KL, Archer GE, Desjardins A, Friedman AH, Friedman HS, Herndon JE, McLendon RE, Reardon DA, Vredenburgh JJ, Bigner DD, et al. Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans. Blood. 118: 3003-12. PMID 21768296 DOI: 10.1182/blood-2011-02-334565  0.44
2011 Desjardins A, Reardon DA, Peters KB, Threatt S, Coan AD, Herndon JE, Friedman AH, Friedman HS, Vredenburgh JJ. A phase I trial of the farnesyl transferase inhibitor, SCH 66336, with temozolomide for patients with malignant glioma. Journal of Neuro-Oncology. 105: 601-6. PMID 21735117 DOI: 10.1007/s11060-011-0627-0  0.44
2011 Nonaka Y, Grossi PM, Bulsara KR, Taniguchi RM, Friedman AH, Fukushima T. Microsurgical management of hypoglossal schwannomas over 3 decades: a modified grading scale to guide surgical approach. Neurosurgery. 69: ons121-40; discussio. PMID 21709593 DOI: 10.1227/NEU.0b013e31822a547b  0.44
2011 Ruden E, Reardon DA, Coan AD, Herndon JE, Hornsby WE, West M, Fels DR, Desjardins A, Vredenburgh JJ, Waner E, Friedman AH, Friedman HS, Peters KB, Jones LW. Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2918-23. PMID 21690470 DOI: 10.1200/JCO.2011.34.9852  0.44
2011 Sampson JH, Raghavan R, Brady M, Friedman AH, Bigner D. Convection-enhanced delivery. Journal of Neurosurgery. 115: 463-4; discussion 46. PMID 21619413 DOI: 10.3171/2010.11.JNS101801  0.44
2011 Reardon DA, Desjardins A, Peters KB, Vredenburgh JJ, Gururangan S, Sampson JH, McLendon RE, Herndon JE, Coan A, Threatt S, Friedman AH, Friedman HS. Phase 2 study of carboplatin, irinotecan, and bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. Cancer. 117: 5351-8. PMID 21590689 DOI: 10.1002/cncr.26188  0.44
2011 Vredenburgh JJ, Desjardins A, Reardon DA, Peters KB, Herndon JE, Marcello J, Kirkpatrick JP, Sampson JH, Bailey L, Threatt S, Friedman AH, Bigner DD, Friedman HS. The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4119-24. PMID 21531816 DOI: 10.1158/1078-0432.CCR-11-0120  0.44
2011 Sampson JH, Herndon JE, Friedman AH, Abernethy AP. Epidemiology. Journal of Neurosurgery. 115: 256-7; discussion 25. PMID 21529133 DOI: 10.3171/2011.1.JNS102066  0.44
2011 Reardon DA, Turner S, Peters KB, Desjardins A, Gururangan S, Sampson JH, McLendon RE, Herndon JE, Jones LW, Kirkpatrick JP, Friedman AH, Vredenburgh JJ, Bigner DD, Friedman HS. A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 414-27. PMID 21464146  0.44
2011 Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, et al. Central nervous system cancers. Journal of the National Comprehensive Cancer Network : Jnccn. 9: 352-400. PMID 21464144  0.44
2011 Sampson JH, Brady M, Raghavan R, Mehta AI, Friedman AH, Reardon DA, Petry NA, Barboriak DP, Wong TZ, Zalutsky MR, Lally-Goss D, Bigner DD. Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans. Neurosurgery. 69: 668-76. PMID 21430586 DOI: 10.1227/NEU.0b013e3182181ba8  0.44
2011 Hodges TR, Karikari IO, Nimjee SM, Tibaleka J, Friedman AH, Cummings TJ, Fukushima T, Friedman AH. Calcifying pseudoneoplasm of the cerebellopontine angle: case report. Neurosurgery. 69: onsE117-20. PMID 21415795 DOI: 10.1227/NEU.0b013e3182155511  0.44
2011 Wanibuchi M, Murakami G, Yamashita T, Minamida Y, Fukushima T, Friedman AH, Fujimiya M, Houkin K. Midsubtemporal ridge as a predictor of the lateral loop formed by the maxillary nerve and mandibular nerve: a cadaveric morphological study. Neurosurgery. 69: ons95-8; discussion . PMID 21346652 DOI: 10.1227/NEU.0b013e31821247f5  0.44
2011 Kanaly CW, Ding D, Mehta AI, Waller AF, Crocker I, Desjardins A, Reardon DA, Friedman AH, Bigner DD, Sampson JH. A novel method for volumetric MRI response assessment of enhancing brain tumors. Plos One. 6: e16031. PMID 21298088 DOI: 10.1371/journal.pone.0016031  0.44
2011 Sampson JH, Aldape KD, Archer GE, Coan A, Desjardins A, Friedman AH, Friedman HS, Gilbert MR, Herndon JE, McLendon RE, Mitchell DA, Reardon DA, Sawaya R, Schmittling R, Shi W, et al. Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma. Neuro-Oncology. 13: 324-33. PMID 21149254 DOI: 10.1093/neuonc/noq157  0.44
2011 Karikari IO, Nimjee SM, Hodges TR, Cutrell E, Hughes BD, Powers CJ, Mehta AI, Hardin C, Bagley CA, Isaacs RE, Haglund MM, Friedman AH. Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: a single-center experience with 102 patients. Neurosurgery. 68: 188-97; discussion 1. PMID 21099707 DOI: 10.1227/NEU.0b013e3181fe3794  0.44
2011 Reardon DA, Desjardins A, Peters K, Gururangan S, Sampson J, Rich JN, McLendon R, Herndon JE, Marcello J, Threatt S, Friedman AH, Vredenburgh JJ, Friedman HS. Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy. Journal of Neuro-Oncology. 103: 371-9. PMID 20853132 DOI: 10.1007/s11060-010-0403-6  0.44
2011 Reardon DA, Vredenburgh JJ, Desjardins A, Peters K, Gururangan S, Sampson JH, Marcello J, Herndon JE, McLendon RE, Janney D, Friedman AH, Bigner DD, Friedman HS. Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma. Journal of Neuro-Oncology. 101: 57-66. PMID 20443129 DOI: 10.1007/s11060-010-0217-6  0.44
2010 Zomorodi A, Bulsara KR, Friedman AH, Alexander MJ. Combined microsurgical and endovascular treatment of a giant left middle cerebral artery aneurysm. Journal of Neurointerventional Surgery. 2: 213-6. PMID 21990628 DOI: 10.1136/jnis.2009.001883  0.44
2010 Jahraus CD, Friedman AH. Chemopotentiation by ultrafractionated radiotherapy in glioblastoma resistant to conventional therapy. Tumori. 96: 771-5. PMID 21302627  0.44
2010 Sampson JH, Heimberger AB, Archer GE, Aldape KD, Friedman AH, Friedman HS, Gilbert MR, Herndon JE, McLendon RE, Mitchell DA, Reardon DA, Sawaya R, Schmittling RJ, Shi W, Vredenburgh JJ, et al. Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 4722-9. PMID 20921459 DOI: 10.1200/JCO.2010.28.6963  0.44
2010 Sameshima T, Fukushima T, McElveen JT, Friedman AH. Critical assessment of operative approaches for hearing preservation in small acoustic neuroma surgery: retrosigmoid vs middle fossa approach. Neurosurgery. 67: 640-4; discussion 64. PMID 20647969 DOI: 10.1227/01.NEU.0000374853.97891.FB  0.44
2010 Ohue S, Fukushima T, Friedman AH, Kumon Y, Ohnishi T. Retrosigmoid suprafloccular transhorizontal fissure approach for resection of brainstem cavernous malformation. Neurosurgery. 66: 306-12; discussion 3. PMID 20489521 DOI: 10.1227/01.NEU.0000369703.67562.BB  0.44
2010 Jones LW, Mourtzakis M, Peters KB, Friedman AH, West MJ, Mabe SK, Kraus WE, Friedman HS, Reardon DA. Changes in functional performance measures in adults undergoing chemoradiation for primary malignant glioma: a feasibility study. The Oncologist. 15: 636-47. PMID 20484122 DOI: 10.1634/theoncologist.2009-0265  0.44
2010 Wanibuchi M, Ohtaki M, Fukushima T, Friedman AH, Houkin K. Skull base training and education using an artificial skull model created by selective laser sintering. Acta Neurochirurgica. 152: 1055-59; discussion . PMID 20401499 DOI: 10.1007/s00701-010-0624-7  0.44
2010 Ohue S, Fukushima T, Kumon Y, Ohnishi T, Friedman AH. Surgical management of brainstem cavernomas: selection of approaches and microsurgical techniques. Neurosurgical Review. 33: 315-22; discussion 3. PMID 20358241 DOI: 10.1007/s10143-010-0256-7  0.44
2010 Ionita CC, Baker J, Graffagnino C, Alexander MJ, Friedman AH, Zaidat OO. Timing of symptomatic vasospasm in aneurysmal subarachnoid hemorrhage: the effect of treatment modality and clinical implications. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 19: 110-5. PMID 20189086 DOI: 10.1016/j.jstrokecerebrovasdis.2009.11.009  0.44
2010 Nonaka Y, Grossi PM, Filomena CA, Friedman AH, Fukushima T. Unilateral hypoglossal nerve palsy caused by an intraneural ganglion cyst. Journal of Neurosurgery. 113: 380-3. PMID 20113159 DOI: 10.3171/2010.1.JNS091526  0.44
2010 Jones LW, Friedman AH, West MJ, Mabe SK, Fraser J, Kraus WE, Friedman HS, Tresch MI, Major N, Reardon DA. Quantitative assessment of cardiorespiratory fitness, skeletal muscle function, and body composition in adults with primary malignant glioma. Cancer. 116: 695-704. PMID 20029975 DOI: 10.1002/cncr.24808  0.44
2010 Sampson JH, Archer G, Pedain C, Wembacher-Schröder E, Westphal M, Kunwar S, Vogelbaum MA, Coan A, Herndon JE, Raghavan R, Brady ML, Reardon DA, Friedman AH, Friedman HS, Rodríguez-Ponce MI, et al. Poor drug distribution as a possible explanation for the results of the PRECISE trial. Journal of Neurosurgery. 113: 301-9. PMID 20020841 DOI: 10.3171/2009.11.JNS091052  0.44
2010 Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Friedman AH, Herndon JE, Marcello J, Norfleet JA, McLendon RE, Sampson JH, Friedman HS. Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma. Journal of Neuro-Oncology. 96: 219-30. PMID 19562254 DOI: 10.1007/s11060-009-9950-0  0.44
2009 Friedman AH. An eclectic review of the history of peripheral nerve surgery. Neurosurgery. 65: A3-8. PMID 19927076 DOI: 10.1227/01.NEU.0000346252.53722.D3  0.44
2009 Sampson JH, Archer GE, Mitchell DA, Heimberger AB, Herndon JE, Lally-Goss D, McGehee-Norman S, Paolino A, Reardon DA, Friedman AH, Friedman HS, Bigner DD. An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme. Molecular Cancer Therapeutics. 8: 2773-9. PMID 19825799 DOI: 10.1158/1535-7163.MCT-09-0124  0.44
2009 Wanibuchi M, Fukushima T, Zenga F, Friedman AH. Simple identification of the third segment of the extracranial vertebral artery by extreme lateral inferior transcondylar-transtubercular exposure (ELITE). Acta Neurochirurgica. 151: 1499-503. PMID 19657583 DOI: 10.1007/s00701-009-0360-z  0.44
2009 Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Sampson JH, McLendon RE, Herndon JE, Friedman HS. Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy. Journal of Neuro-Oncology. 95: 393-400. PMID 19533023 DOI: 10.1007/s11060-009-9937-x  0.44
2009 Affronti ML, Heery CR, Herndon JE, Rich JN, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Bigner DD, Friedman HS. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. Cancer. 115: 3501-11. PMID 19514083 DOI: 10.1002/cncr.24398  0.44
2009 Friedman AH, Elias WJ, Midha R. Introduction: peripheral nerve surgery--biology, entrapment, and injuries. Neurosurgical Focus. 26: E1. PMID 19435439 DOI: 10.3171/FOC.2009.26.2.E1  0.44
2009 Perry SL, Bohlin C, Reardon DA, Desjardins A, Friedman AH, Friedman HS, Vredenburgh JJ. Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients. Journal of Neuro-Oncology. 95: 129-34. PMID 19415455 DOI: 10.1007/s11060-009-9911-7  0.44
2009 Karikari IO, Powers CJ, Bagley CA, Cummings TJ, Radhakrishnan S, Friedman AH. Primary intramedullary melanocytoma of the spinal cord: case report. Neurosurgery. 64: E777-8; discussion E. PMID 19349809 DOI: 10.1227/01.NEU.0000341516.22126.AA  0.44
2009 Wanibuchi M, Fukushima T, McElveen JT, Friedman AH. Hearing preservation in surgery for large vestibular schwannomas. Journal of Neurosurgery. 111: 845-54. PMID 19344218 DOI: 10.3171/2008.12.JNS08620  0.44
2009 Shamji MF, Allen KD, So S, Jing L, Adams SB, Schuh R, Huebner J, Kraus VB, Friedman AH, Setton LA, Richardson WJ. Gait abnormalities and inflammatory cytokines in an autologous nucleus pulposus model of radiculopathy. Spine. 34: 648-54. PMID 19333095 DOI: 10.1097/BRS.0b013e318197f013  0.44
2009 Voyvodic JT, Petrella JR, Friedman AH. fMRI activation mapping as a percentage of local excitation: consistent presurgical motor maps without threshold adjustment. Journal of Magnetic Resonance Imaging : Jmri. 29: 751-9. PMID 19306363 DOI: 10.1002/jmri.21716  0.44
2009 Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE, Walker A, Friedman HS. Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma. Neuro-Oncology. 11: 556-61. PMID 19289491 DOI: 10.1215/15228517-2009-007  0.44
2009 Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, et al. IDH1 and IDH2 mutations in gliomas. The New England Journal of Medicine. 360: 765-73. PMID 19228619 DOI: 10.1056/NEJMoa0808710  0.44
2009 Jones LW, Cohen RR, Mabe SK, West MJ, Desjardins A, Vredenburgh JJ, Friedman AH, Reardon DA, Waner E, Friedman HS. Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing. Journal of Neuro-Oncology. 94: 79-85. PMID 19212703 DOI: 10.1007/s11060-009-9803-x  0.44
2009 Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE, Walker A, Friedman HS. Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1262-7. PMID 19204199 DOI: 10.1200/JCO.2008.18.8417  0.44
2009 Quinn JA, Jiang SX, Carter J, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE, Threatt S, Friedman HS. Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1064-8. PMID 19188181 DOI: 10.1158/1078-0432.CCR-08-2130  0.44
2009 Bullitt E, Ewend M, Vredenburgh J, Friedman A, Lin W, Wilber K, Zeng D, Aylward SR, Reardon D. Computerized assessment of vessel morphological changes during treatment of glioblastoma multiforme: report of a case imaged serially by MRA over four years. Neuroimage. 47: T143-51. PMID 19103295 DOI: 10.1016/j.neuroimage.2008.10.067  0.44
2008 Husain AM, Wright DR, Stolp BW, Friedman AH, Keifer JC. Neurophysiological intraoperative monitoring of the glossopharyngeal nerve: Technical case report Neurosurgery. 63: ONS277-ONS278. PMID 18981820  0.44
2008 Desjardins A, Reardon DA, Herndon JE, Marcello J, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Bailey L, Bigner DD, Friedman AH, Friedman HS, Vredenburgh JJ. Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 7068-73. PMID 18981004 DOI: 10.1158/1078-0432.CCR-08-0260  0.44
2008 Bulsara KR, Sameshima T, Friedman AH, Fukushima T. Microsurgical management of 53 jugular foramen schwannomas: Lessons learned incorporated into a modified grading system - Clinical article Journal of Neurosurgery. 109: 794-803. PMID 18976067 DOI: 10.3171/JNS/2008/109/11/0794  0.44
2008 Shamji MF, Jing L, Chen J, Hwang P, Ghodsizadeh O, Friedman AH, Richardson WJ, Setton LA. Treatment of neuroinflammation by soluble tumor necrosis factor receptor Type II fused to a thermally responsive carrier. Journal of Neurosurgery. Spine. 9: 221-8. PMID 18764758 DOI: 10.3171/SPI/2008/9/8/221  0.44
2008 Maxwell JA, Johnson SP, McLendon RE, Lister DW, Horne KS, Rasheed A, Quinn JA, Ali-Osman F, Friedman AH, Modrich PL, Bigner DD, Friedman HS. Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4859-68. PMID 18676759 DOI: 10.1158/1078-0432.CCR-07-4807  0.44
2008 Shamji MF, Chen J, Friedman AH, Richardson WJ, Chilkoti A, Setton LA. Synthesis and characterization of a thermally-responsive tumor necrosis factor antagonist. Journal of Controlled Release : Official Journal of the Controlled Release Society. 129: 179-86. PMID 18547669 DOI: 10.1016/j.jconrel.2008.04.021  0.44
2008 Brem SS, Bierman PJ, Black P, Brem H, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Glass J, Grossman SA, Heimberger AB, Junck L, Linette GP, et al. Central nervous system cancers. Journal of the National Comprehensive Cancer Network : Jnccn. 6: 456-504. PMID 18492461  0.44
2008 Everson RG, Graner MW, Gromeier M, Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS, Friedman AH, Bigner DD, Sampson JH. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma. Expert Review of Anticancer Therapy. 8: 717-32. PMID 18471045 DOI: 10.1586/14737140.8.5.717  0.44
2008 Sampson JH, Akabani G, Archer GE, Berger MS, Coleman RE, Friedman AH, Friedman HS, Greer K, Herndon JE, Kunwar S, McLendon RE, Paolino A, Petry NA, Provenzale JM, Reardon DA, et al. Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. Neuro-Oncology. 10: 320-9. PMID 18403491 DOI: 10.1215/15228517-2008-012  0.44
2008 Choi JD, Powers CJ, Vredenburgh JJ, Friedman AH, Sampson JH. Cryptococcal meningitis in patients with glioma: A report of two cases Journal of Neuro-Oncology. 89: 51-53. PMID 18398572 DOI: 10.1007/s11060-008-9581-x  0.44
2008 Shamji MF, Whitlatch L, Friedman AH, Richardson WJ, Chilkoti A, Setton LA. An injectable and in situ-gelling biopolymer for sustained drug release following perineural administration. Spine. 33: 748-54. PMID 18379401 DOI: 10.1097/BRS.0b013e3181695773  0.44
2008 Reardon DA, Desjardins A, Vredenburgh JJ, Sathornsumetee S, Rich JN, Quinn JA, Lagattuta TF, Egorin MJ, Gururangan S, McLendon R, Herndon JE, Friedman AH, Salvado AJ, Friedman HS. Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma. Neuro-Oncology. 10: 330-40. PMID 18359865 DOI: 10.1215/15228517-2008-003  0.44
Show low-probability matches.